These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24614758)

  • 1. Regulation of T cell differentiation and alloimmunity by the cyclin-dependent kinase inhibitor p18ink4c.
    Rowell EA; Wang L; Chunder N; Hancock WW; Wells AD
    PLoS One; 2014; 9(3):e91587. PubMed ID: 24614758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cyclin-dependent kinase inhibitor p27kip1 is required for transplantation tolerance induced by costimulatory blockade.
    Rowell EA; Wang L; Hancock WW; Wells AD
    J Immunol; 2006 Oct; 177(8):5169-76. PubMed ID: 17015702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing roles for the cyclin-dependent kinase inhibitor p27kip1 in the control of CD4+ T cell proliferation and effector function.
    Rowell EA; Walsh MC; Wells AD
    J Immunol; 2005 Mar; 174(6):3359-68. PubMed ID: 15749868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics.
    Appleman LJ; Tzachanis D; Grader-Beck T; van Puijenbroek AA; Boussiotis VA
    J Mol Med (Berl); 2001; 78(12):673-83. PubMed ID: 11434720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell effector function and anergy avoidance are quantitatively linked to cell division.
    Wells AD; Walsh MC; Sankaran D; Turka LA
    J Immunol; 2000 Sep; 165(5):2432-43. PubMed ID: 10946268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gata3 restrains B cell proliferation and cooperates with p18INK4c to repress B cell lymphomagenesis.
    Liu S; Chan HL; Bai F; Ma J; Scott A; Robbins DJ; Capobianco AJ; Zhu P; Pei XH
    Oncotarget; 2016 Sep; 7(39):64007-64020. PubMed ID: 27588406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin-dependent kinase 2 controls peripheral immune tolerance.
    Chunder N; Wang L; Chen C; Hancock WW; Wells AD
    J Immunol; 2012 Dec; 189(12):5659-66. PubMed ID: 23136201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
    Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH
    J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease.
    Kato K; Cui S; Kuick R; Mineishi S; Hexner E; Ferrara JL; Emerson SG; Zhang Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):751-71. PubMed ID: 20116439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.
    Pozo D; Anderson P; Gonzalez-Rey E
    J Immunol; 2009 Oct; 183(7):4346-59. PubMed ID: 19734220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle regulation during mouse olfactory neurogenesis.
    Legrier ME; Ducray A; Propper A; Chao M; Kastner A
    Cell Growth Differ; 2001 Dec; 12(12):591-601. PubMed ID: 11751454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing NK cell activation by donor dendritic cells enhances allospecific CD4 T cell priming and promotes Th type 2 responses to transplantation antigens.
    Coudert JD; Coureau C; Guéry JC
    J Immunol; 2002 Sep; 169(6):2979-87. PubMed ID: 12218112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
    Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.
    Gonzalez M; Quezada SA; Blazar BR; Panoskaltsis-Mortari A; Rudensky AY; Noelle RJ
    J Immunol; 2002 Nov; 169(10):5581-9. PubMed ID: 12421935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the requirements for the induction of CD4+ T cell alloantigen hyporesponsiveness by ex vivo anti-CD40 ligand antibody.
    Taylor PA; Panoskaltsis-Mortari A; Noelle RJ; Blazar BR
    J Immunol; 2000 Jan; 164(2):612-22. PubMed ID: 10623802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen.
    Thorstenson KM; Khoruts A
    J Immunol; 2001 Jul; 167(1):188-95. PubMed ID: 11418648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIM-3: a novel regulatory molecule of alloimmune activation.
    Boenisch O; D'Addio F; Watanabe T; Elyaman W; Magee CN; Yeung MY; Padera RF; Rodig SJ; Murayama T; Tanaka K; Yuan X; Ueno T; Jurisch A; Mfarrej B; Akiba H; Yagita H; Najafian N
    J Immunol; 2010 Nov; 185(10):5806-19. PubMed ID: 20956339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
    Wells AD; Walsh MC; Bluestone JA; Turka LA
    J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.